253 related articles for article (PubMed ID: 30334378)
1. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
[TBL] [Abstract][Full Text] [Related]
2. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.
Maschio M; Dinapoli L; Mingoia M; Sperati F; Pace A; Pompili A; Carapella CM; Vidiri A; Muti P
J Neurol; 2011 Nov; 258(11):2100-4. PubMed ID: 21674196
[TBL] [Abstract][Full Text] [Related]
4. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study.
Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R
J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759
[TBL] [Abstract][Full Text] [Related]
5. NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.
Villanueva V; Saiz-Diaz R; Toledo M; Piera A; Mauri JA; Rodriguez-Uranga JJ; López-González FJ; Gómez-Ibáñez A; Garcés M; González de la Aleja J; Rodríguez-Osorio X; Palao-Duarte S; Castillo A; Bonet M; Ruiz-Giménez J; Palau J; Arcediano A; Toledo M; Gago A
Epilepsy Behav; 2016 Dec; 65():25-32. PubMed ID: 27863278
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
[TBL] [Abstract][Full Text] [Related]
7. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH
Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339
[TBL] [Abstract][Full Text] [Related]
8. Management of epilepsy in brain tumor patients.
van der Meer PB; Taphoorn MJB; Koekkoek JAF
Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
10. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
Kalilani L; Halpern R; Seare J; Dedeken P
Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study.
Koekkoek JA; Kerkhof M; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Bromberg JE; van den Bent MJ; Reijneveld JC; Taphoorn MJ
BMC Neurol; 2014 Aug; 14():157. PubMed ID: 25124385
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
Sutter R; Marsch S; Rüegg S
CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
[TBL] [Abstract][Full Text] [Related]
13. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
[TBL] [Abstract][Full Text] [Related]
14. Isobolographic additivity among lacosamide, lamotrigine and phenobarbital in a mouse tonic-clonic seizure model.
Kondrat-Wróbel MW; Łuszczki JJ
Adv Clin Exp Med; 2018 Jul; 27(7):881-886. PubMed ID: 29616753
[TBL] [Abstract][Full Text] [Related]
15. Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome.
Tayama T; Mori T; Goji A; Toda Y; Kagami S
Brain Dev; 2020 Jun; 42(6):473-476. PubMed ID: 32247529
[TBL] [Abstract][Full Text] [Related]
16. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.
Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D
Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study.
Borzì G; Di Gennaro G; Schmitt FC; D'Aniello A; Mumoli L; Zummo L; Daniele O; Russo E; Gambardella A; Labate A
Epilepsy Behav; 2016 May; 58():111-4. PubMed ID: 27064831
[TBL] [Abstract][Full Text] [Related]
20. Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study.
Rudà R; Pellerino A; Franchino F; Bertolotti C; Bruno F; Mo F; Migliore E; Ciccone G; Soffietti R
J Neurooncol; 2018 Jan; 136(1):105-114. PubMed ID: 29030718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]